 |
|
Cutaneous and Subcutaneous Inflammatory Sclerosis Syndromes
John A. Doyle, MB;
Suzanne M. Connolly, MD;
R. K. Winkelmann, MD, PhD
Arch Dermatol. 1982;118(11):886-890.
Abstract
• Systemic scleroderma and localized scleroderma (morphea) show comparable changes on skin biopsy specimens, and a distinction has often been made on the basis of Raynaud's phenomenon, organ involvement, and laboratory abnormalities characteristically seen in systemic scleroderma. Critical evaluation not only of patients with localized scleroderma but also of those with eosinophilic fasciitis, morphea profunda, and acral pansclerotic morphea has disclosed Raynaud's phenomenon, organ involvement, and laboratory abnormalities typical of systemic scleroderma in a small percentage of patients. Histologically, all five conditions show similar inflammation and sclerosis of the skin, the primary difference being the depth at which these changes occur. These conditions may possibly be related, and the clinical and laboratory differences observed may result from variations in depth, nature, and intensity of the cutaneous and subcutaneous inflammatory sclerosis.
(Arch Dermatol 1982;118:886-890)
Author Affiliations
From the Department of Dermatology, Mayo Clinic and Mayo Foundation, Rochester, Minn.
Footnotes
Accepted for publication Feb 16, 1982.
Reprint requests to Mayo Clinic, Rochester, MN 55905 (Dr Doyle).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Management of tenosynovitis in linear scleroderma
Hartwright et al.
Rheumatology (Oxford) 2006;45:640-641.
FULL TEXT
An Unusual Case of Relapsing Myositis In a 12-Year-Old Child
Lucas and Urbach
CLIN PEDIATR 1993;32:438-442.
Eosinophilic Fasciitis: Increased Collagen Production and Type I Procollagen Messenger RNA Levels in Fibroblasts Cultured From Involved Skin
Kahari et al.
Arch Dermatol 1990;126:613-617.
ABSTRACT
Picture of the Month
Iyer et al.
Arch Pediatr Adolesc Med 1989;143:1353-1354.
ABSTRACT
Linear Scleroderma: Clinical Spectrum, Prognosis, and Laboratory Abnormalities
FALANGA et al.
ANN INTERN MED 1986;104:849-857.
ABSTRACT
Subcutaneous Sclerosis With Fasciitis and Eosinophilia After Phytonadione Injections
Janin-Mercier et al.
Arch Dermatol 1985;121:1421-1423.
ABSTRACT
High Titers of Antibodies to Single-Stranded DNA in Linear Scleroderma: Vincent Falanga, MD; Thomas A. Medsger, MD; Morris Reichlin, MD
Arch Dermatol 1985;121:345-347.
ABSTRACT
Panniculitis in Connective Tissue Disease
Winkelmann
Arch Dermatol 1983;119:336-344.
ABSTRACT
|
